Sweden
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
67.63%
|
Dec. 31, 2023 | USD 3.33 | 0.41% |
|
Sweden |
|
2 |
66.65%
|
Dec. 31, 2023 | USD 13.60 | 0.68% |
|
Sweden |
|
3 |
55.87%
|
Dec. 31, 2023 | USD 5.03 | -0.03% |
|
Sweden |
|
4 |
55.76%
|
Dec. 31, 2023 | USD 0.47 | 0.81% |
|
Sweden |
|
5 |
49.29%
|
Dec. 31, 2023 | USD 8.38 | 0.57% |
|
Sweden |
|
6 |
49.12%
|
Dec. 31, 2023 | USD 0.19 | -0.75% |
|
Sweden |
|
7 |
46.93%
|
Dec. 31, 2023 | USD 2.88 | 0.37% |
|
Sweden |
|
8 |
41.36%
|
Dec. 31, 2023 | USD 5.68 | 4.11% |
|
Sweden |
|
9 |
38.25%
|
Dec. 31, 2023 | USD 3.38 | -2.41% |
|
Sweden |
|
10 |
37.60%
|
Dec. 31, 2023 | USD 9.44 | 1.16% |
|
Sweden |
|
11 |
37.00%
|
Dec. 31, 2023 | USD 2.97 | 0.98% |
|
Sweden |
|
12 |
36.00%
|
Dec. 31, 2023 | USD 4.61 | 2.06% |
|
Sweden |
|
13 |
35.77%
|
Dec. 31, 2023 | USD 51.72 | -0.10% |
|
Sweden |
|
14 |
35.72%
|
Dec. 31, 2023 | USD 5.99 | 1.28% |
|
Sweden |
|
15 |
34.91%
|
Dec. 31, 2023 | USD 9.91 | 1.41% |
|
Sweden |
|
16 |
34.85%
|
Dec. 31, 2023 | USD 2.11 | 2.63% |
|
Sweden |
|
17 |
34.07%
|
Dec. 31, 2023 | USD 23.79 | -0.07% |
|
Sweden |
|
18 |
33.86%
|
Dec. 31, 2023 | USD 16.17 | -0.15% |
|
Sweden |
|
19 |
32.36%
|
Dec. 31, 2023 | USD 2.45 | 1.04% |
|
Sweden |
|
20 |
32.07%
|
Dec. 31, 2023 | USD 24.41 | 2.36% |
|
Sweden |
|
21 |
31.87%
|
April 30, 2024 | USD 22.17 | -0.20% |
|
Sweden |
|
22 |
30.89%
|
Dec. 31, 2023 | USD 36.51 | 2.02% |
|
Sweden |
|
23 |
30.65%
|
Dec. 31, 2023 | USD 0.90 | 2.09% |
|
Sweden |
|
24 |
30.47%
|
Dec. 31, 2023 | USD 3.05 | 0.68% |
|
Sweden |
|
25 |
30.17%
|
Dec. 31, 2023 | USD 6.50 | -2.66% |
|
Sweden |
|
26 |
30.09%
|
June 30, 2024 | USD 3.46 | 1.94% |
|
Sweden |
|
27 |
29.01%
|
Dec. 31, 2023 | USD 15.69 | 1.43% |
|
Sweden |
|
28 |
28.30%
|
Dec. 31, 2023 | USD 1.32 | 3.12% |
|
Sweden |
|
29 |
27.78%
|
Dec. 31, 2023 | USD 10.50 | 2.24% |
|
Sweden |
|
30 |
26.80%
|
Dec. 31, 2023 | USD 31.50 | -0.03% |
|
Sweden |
|
31 |
26.09%
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
32 |
25.90%
|
Dec. 31, 2023 | USD 76.06 | 1.75% |
|
Sweden |
|
33 |
25.77%
|
Dec. 31, 2023 | USD 17.25 | 1.52% |
|
Sweden |
|
34 |
25.24%
|
Dec. 31, 2023 | USD 5.56 | -0.91% |
|
Sweden |
|
35 |
25.20%
|
Dec. 31, 2023 | USD 1.27 | 1.67% |
|
Sweden |
|
36 |
24.98%
|
Dec. 31, 2023 | USD 13.01 | 0.61% |
|
Sweden |
|
37 |
24.96%
|
Dec. 31, 2023 | USD 4.83 | 2.53% |
|
Sweden |
|
38 |
24.80%
|
Dec. 31, 2023 | USD 32.66 | 2.35% |
|
Sweden |
|
39 |
24.32%
|
Dec. 31, 2023 | USD 4.28 | -0.81% |
|
Sweden |
|
40 |
24.04%
|
Dec. 31, 2023 | USD 19.05 | 2.21% |
|
Sweden |
|
41 |
23.04%
|
Dec. 31, 2023 | USD 9.64 | 1.81% |
|
Sweden |
|
42 |
22.39%
|
Dec. 31, 2023 | USD 8.75 | 1.09% |
|
Sweden |
|
43 |
22.24%
|
Dec. 31, 2023 | USD 31.18 | 3.82% |
|
Sweden |
|
44 |
22.20%
|
Dec. 31, 2023 | USD 0.28 | 1.31% |
|
Sweden |
|
45 |
21.97%
|
Dec. 31, 2023 | USD 9.75 | -0.95% |
|
Sweden |
|
46 |
21.96%
|
Dec. 31, 2023 | USD 3.77 | -0.64% |
|
Sweden |
|
47 |
21.95%
|
Dec. 31, 2023 | USD 12.50 | 1.33% |
|
Sweden |
|
48 |
21.77%
|
April 30, 2024 | USD 18.21 | 0.29% |
|
Sweden |
|
49 |
21.57%
|
Dec. 31, 2023 | USD 8.95 | 0.78% |
|
Sweden |
|
50 |
21.53%
|
March 31, 2024 | USD 25.75 | 0.96% |
|
Sweden |
The company in Sweden with the highest Return on Capital Employed (ROCE) is Sleep Cycle AB (publ) (Stockholm Stock Exchange: SLEEP.ST) at 67.63%.
The company in Sweden with the lowest Return on Capital Employed (ROCE) is Goodbye Kansas Group AB (publ) (Stockholm Stock Exchange: GBK.ST) at -452.88%.
The top 10 companies in Sweden by Return on Capital Employed (ROCE) are Sleep Cycle AB (publ), Ework Group AB (publ), Generic Sweden AB, ContextVision AB (publ), engcon AB (publ), Clavister Holding AB (publ.), Ogunsen AB (publ), Dedicare AB (publ), Profoto Holding AB (publ) and SinterCast AB (publ).
The bottom 10 companies in Sweden by Return on Capital Employed (ROCE) are Goodbye Kansas Group AB (publ), LifeClean International AB (publ), Viaplay Group AB (publ), Clinical Laserthermia Systems AB (publ), Prostatype Genomics AB (publ), Freja eID Group AB (publ), Oncopeptides AB (publ), Biovica International AB (publ), SynAct Pharma AB and Readly International AB (publ).